IRIS
MURINEDDU, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.744
EU - Europa 1.534
AS - Asia 1.102
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 8
AF - Africa 6
AN - Antartide 1
Totale 5.417
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.729
UA - Ucraina 673
CN - Cina 665
SG - Singapore 315
DE - Germania 245
IT - Italia 197
SE - Svezia 137
FI - Finlandia 108
TR - Turchia 79
GB - Regno Unito 54
FR - Francia 43
BE - Belgio 31
KR - Corea 15
CA - Canada 13
CZ - Repubblica Ceca 13
AU - Australia 12
EU - Europa 8
IN - India 8
IR - Iran 8
RO - Romania 7
BR - Brasile 5
ES - Italia 4
EG - Egitto 3
JP - Giappone 3
NL - Olanda 3
BG - Bulgaria 2
DK - Danimarca 2
HU - Ungheria 2
IQ - Iraq 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BD - Bangladesh 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
DZ - Algeria 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HK - Hong Kong 1
IL - Israele 1
JM - Giamaica 1
MC - Monaco 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TH - Thailandia 1
VG - Isole Vergini Britanniche 1
ZA - Sudafrica 1
Totale 5.417
Salva come PNG Salva come JPEG
Città #
Chandler 675
Jacksonville 417
Princeton 238
Singapore 237
Dearborn 216
Nanjing 192
Ann Arbor 109
Wilmington 105
New York 81
Izmir 76
Sassari 61
Ashburn 58
Nanchang 56
Shenyang 56
Beijing 54
Woodbridge 46
Hebei 43
Changsha 38
Jiaxing 31
Brussels 30
Tianjin 29
Kunming 22
Boardman 21
Andover 19
Ningbo 19
Santa Clara 19
Jinan 17
San Mateo 17
Hangzhou 16
Mountain View 16
Norwalk 16
Guangzhou 15
Seoul 15
San Francisco 13
Helsinki 12
Rome 12
Taizhou 12
Monmouth Junction 11
Munich 11
Zhengzhou 11
Toronto 10
Augusta 9
Brno 9
Dallas 9
Auburn Hills 8
Lanzhou 8
Albissola Marina 7
Leawood 7
Los Angeles 7
Edinburgh 6
Quartu Sant'Elena 6
Frankfurt am Main 5
Hanover 5
Horia 5
London 5
Melbourne 5
Shanghai 5
Ardabil 4
Changchun 4
Houston 4
São Paulo 4
Alghero 3
Cagliari 3
Haikou 3
Olomouc 3
Paris 3
Perugia 3
Romola 3
Tokyo 3
Aversa 2
Bariano 2
Budapest 2
Canberra 2
Castel Gandolfo 2
Fuzhou 2
Genoa 2
Hefei 2
Huskvarna 2
Incisa 2
Media 2
Montreal 2
Mumbai 2
Nutley 2
Palermo 2
Prineville 2
Quartucciu 2
Seattle 2
Shenzhen 2
Sofia 2
Wuxi 2
Xi'an 2
Aarau 1
Abuja 1
Algiers 1
Amsterdam 1
Arbatax 1
Atlanta 1
Baghdad 1
Bangalore 1
Bangkok 1
Totale 3.351
Salva come PNG Salva come JPEG
Nome #
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 85
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 80
The organic chemistry of drug design and drug action 72
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2 ',4 '-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyra zole-3-carboxamide 71
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues 69
Chiral pyridine N-oxides useful ligands for asymmetric catalysis 69
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 69
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers 69
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors 69
Approcci terapeutici contro il cancro. Tradizione e innovazione. 68
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 68
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 65
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 64
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 63
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 63
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 63
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6- tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. 62
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 62
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors 61
Composti farmaceutici 61
An overview on different classes of viral entry and respiratory syncitial virus (RSV) fusion inhibitors 59
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors 59
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 58
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety 57
CAPITOLO 41. Antielmintici 56
Synthesis and cytotoxicity evaluation of thiophene analogues of 1-methyl-2,3-bis(hydroxymethyl)benzo[g]indole bis[N-(2-propyl)carbamate] 55
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 55
Tricyclic pyrazole derivatives as cannabinoid receptor antagonist 54
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 53
Development and characterization of novel cannabinoid derivatives based on diarylpyridazine scaffold. 53
Design, Synthesis and preliminary biological data of new ligands for neuronal nicotinic acetylcholine receptors 53
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 52
Design of a new class of chiral C2-symmetric dipyridylmethane ligands and their application in asymmetric catalysis 52
I 3,6-diazabiciclo[3.1.1]eptani: una nuova serie di potenti agonisti per i recettori μ degli oppioidi 51
Manuale di chimica farmaceutica. Progettazione, meccanismo d'azione e metabolismo dei farmaci 51
Pharmaceutical Compounds 51
Novel diazabicycloalkane delta opioid agonists 51
Sintesi di 1,10-fenantroline chirali a simmetria C2 derivati da monoterpeni naturali quali utili leganti per la catalisi asimmetrica 51
Oxadiazoles having antiproliferative activity 50
Oxadiazoles having anti proliferative activity 50
Ossadiazoli ad attività antiproliferativa 50
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzolglindazole-based ligands for cannabinoid receptors 49
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands 49
Synthesis and biological evaluation of novel CB2 ligands 49
Tricyclic pyrazoles. Part 3. Synthesis, biological evaluation and molecular modelling of analogues of the cannabinoid antagonist NESS 0327 49
Synthesis and cytotoxicity of substituted 2-benzylnaphth[2,3-d]imidazoles 49
Synthesis of biologically active bridged diazabicycloheptanes 48
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 48
Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties 48
Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors 48
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 48
Synthesis, modelling, and m-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes 47
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 47
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 47
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 47
Pharmaceutical compounds 47
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides 46
3-(5-Phenyl[1,3,4]oxadiazol-2-yl)-1H-benzo]g]indole and related compounds: synthesis and cytotoxic acitivities 46
Ring-fused pyrazole derivates as ligands for cannabinoid receptors: synthesis and investigation of structure-activity relationships 45
Pharmaceutical compounds 45
Synthesis and application in asymmetric copper(I)-catalyzed allylic oxidation of a new chiral 1,10-phenantroline derived from pinene 44
Different classes of CB2 Ligands Potentially Useful in the Treatment of Pain. 44
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as μ-opioid receptor agonists. Effects on μ-affinity of arylalkenyl chain modifications 44
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 44
Synthesis and μ-opioid receptor affinity of fused .bicyclic analogues of N-3(9)-Arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes (DBNs) 43
Synthesis and analgesic-antiinflammatory activities of novel acylarylhydrazones with a 5-phenyl-4-R-3-pyrrolyl-acyl moiety 43
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 43
Pharmaceutical compounds 42
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives 42
Synthesis and tumor cell lines inhibition of 1,3,4.oxadiazoles linked to tricyclic pyrroles 42
Synthesis of chiral C2-symmetric 1,10-phenanthrolines from naturally occurring monoterpenes 41
NESS06SM reduces body weight with an improved profile relative to SR141716A 41
Sintesi di nuovi diazatriciclodicani (DTDs). Effetto della variazione strutturale della catena cinnamilica sulla μ-affinità e sull’analgesia oppioide 41
Tricyciclic Pyrazoles. Synthesis and bilogical evaluation of novel 4,5-dihydro-1H-6-oxa-cicloepta[1,2-c]pyrazole-based analogues of cannabinoid antagonist NESS-0327 41
Pharmaceutical compounds 41
RNA-viruses. Enzymatic and receptorial inhibitors. Research signpost keral, India, (RNA-viruses. Enzymatic and recptoral inhibitors. 40
Chimica farmaceutica 40
Chimica farmaceutica. Con e-book 40
Synthesis and μ-opioid receptor affinity of heteroaromatic analogues of N-3(9)-Arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes (DBNs) 40
Pharmaceutical compounds 39
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors 39
Sintesi di nuovi leganti chirali dipiridilmetanici e loro applicazione nella sostituzione allilica palladio-catalizzata 38
Myrtanil substituent in 3 position of pirazole ring determines CB1 agonism of novel 4,5-dihydrobenzo-oxa-cycloheptapyrazole cannabinoids 38
Substituted 3,8-diazabicyclo[3.2.1]octane compounds 38
I farmaci antivirali. Dalla progettazione all’impiego terapeutico. 38
Pharmaceutical compounds 37
Synthesis and cytotoxic activities of 3-(5-phenyl-[1.3.4]oxadiazol-2-yl)-1H-benzo[g]indole and related compounds 37
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazoles: A versatile architecture for CB2 selective ligands 37
Sintesi e affinità per i recettori oppioidi di nuovi N3-propionil-N6-naftilprop(en)il-3,6-diazabiciclo[3.3.1]eptani 37
New tricyclic pyrazole derivatives as CB1 antagonists having improved activity towards food intake and weight control 36
Oxadiazoles having antiproliferative activity 36
Versatility of the pyridazine system: chemistry and biology 36
Pharmaceutical compounds 35
Pharmaceutical Compounds 35
Diazacyclic compounds having affinity for opioid receptors 35
Principi generali. In: Chimica Tossicologica 35
A survey of Recent Patents on CB2 Agonists in the Management of Pain 35
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 34
Synthesis, Pharmacological Evaluation and Docking Studies of Pyrrole Structure-Based CB2 Receptor Antagonists 34
Pyrazolo-naphthyridines: Design and Synthesis of potential CB-ligands 33
Totale 4.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020800 0 0 0 0 103 188 218 15 126 38 109 3
2020/2021920 110 5 138 12 111 32 124 23 128 135 82 20
2021/2022572 67 6 9 7 8 5 28 48 51 37 61 245
2022/20231.271 130 78 27 229 110 210 2 161 228 8 56 32
2023/2024396 58 26 15 7 37 81 1 55 3 4 50 59
2024/2025389 20 20 186 59 104 0 0 0 0 0 0 0
Totale 5.517